These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8446966)

  • 21. Expression of diphtheria toxin A-chain in mature B-cells: a potential approach to therapy of B-lymphoid malignancy.
    Maxwell IH; Glode LM; Maxwell F
    Leuk Lymphoma; 1992 Aug; 7(5-6):457-62. PubMed ID: 1493446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.
    Liu J; Woffendin C; Yang ZY; Nabel GJ
    Gene Ther; 1994 Jan; 1(1):32-7. PubMed ID: 7584057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-specific expression of the diphtheria toxin A-chain coding sequence induces cancer cell suicide.
    Rui H; Chen Y
    Chin Med J (Engl); 2002 Jun; 115(6):869-73. PubMed ID: 12123555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor effect of diphtheria toxin A-chain gene-containing cationic liposomes conjugated with monoclonal antibody directed to tumor-associated antigen of bovine leukemia cells.
    Tana ; Watarai S; Onuma M; Aida Y; Kakidani H; Kodama H; Yasuda T
    Jpn J Cancer Res; 1998 Nov; 89(11):1202-11. PubMed ID: 9914790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
    Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
    Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication.
    Konopka K; Lee NS; Rossi J; Düzgüneş N
    Gene; 2000 Sep; 255(2):235-44. PubMed ID: 11024283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells.
    Kim YS; Panganiban AT
    J Neurosci Res; 1996 Mar; 43(6):652-66. PubMed ID: 8984195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-regulated expression of attenuated diphtheria toxin A fused with hypoxia-inducible factor-1alpha oxygen-dependent degradation domain preferentially induces apoptosis of hypoxic cells in solid tumor.
    Koshikawa N; Takenaga K
    Cancer Res; 2005 Dec; 65(24):11622-30. PubMed ID: 16357173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant.
    Ventura AM; Arens MQ; Srinivasan A; Chinnadurai G
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1310-4. PubMed ID: 2137611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase.
    Srivastava DK; Tendler CL; Milani D; English MA; Licht JD; Wilson SH
    AIDS; 2001 Mar; 15(4):433-40. PubMed ID: 11242139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
    Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
    Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tat-dependent conditionally replicating adenoviruses expressing diphtheria toxin A for specifically killing HIV-1-infected cells.
    Ni F; Hu K; Li M; Yang M; Xiao Y; Fu M; Zhu Z; Liu Y; Hu Q
    Mol Ther; 2024 Jul; 32(7):2316-2327. PubMed ID: 38734901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo antitumor effect of cationic liposomes containing diphtheria toxin A-chain gene on cells infected with bovine leukemia virus.
    Tana ; Watarai S; Lee JT; Onuma M; Ochiai K; Kakidani H; Yasuda T
    J Vet Med Sci; 1997 Jul; 59(7):617-9. PubMed ID: 9271462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressive effect of liposomes containing DNA coding for diphtheria toxin A-chain on cells transformed with bovine leukemia virus.
    Kakidani H; Watarai S; Onuma M; Tomochika K; Yasuda T
    Microbiol Immunol; 1993; 37(9):713-20. PubMed ID: 8271974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
    Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
    Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
    Twu JS; Chu K; Robinson WS
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, cytotoxic properties and effects on early and late gene induction of a chimeric diphtheria toxin-leukemia-inhibitory factor protein.
    Negro A; Skaper SD
    Eur J Biochem; 1996 Oct; 241(2):507-15. PubMed ID: 8917449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetracycline-controlled expression but not toxicity of an attenuated diphtheria toxin mutant.
    Keyvani K; Baur I; Paulus W
    Life Sci; 1999; 64(19):1719-24. PubMed ID: 10353625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
    West MJ; Karn J
    EMBO J; 1999 Mar; 18(5):1378-86. PubMed ID: 10064603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.